For example, small molecule stabilizers had been designed to enhance the binding capacity of 14-3-3 sigma to estrogen receptor α (Erα), which is a potent driver of tumor cell growth in breast cancer, resulting in decreased transcriptional activity of ERα [33,34]. Here, SFN is linked to breast cancer.